Gyrodyne , LLC (NASDAQ:GYRO – Get Free Report) was the target of a significant decrease in short interest in the month of August. As of August 31st, there was short interest totaling 417 shares, a decrease of 67.8% from the August 15th total of 1,295 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 2,661 shares, the short-interest ratio is presently 0.2 days.
Gyrodyne Stock Performance
GYRO stock traded up $0.07 on Friday, hitting $5.06. 13,130 shares of the company were exchanged, compared to its average volume of 3,040. Gyrodyne has a twelve month low of $4.95 and a twelve month high of $10.90. The business’s fifty day moving average is $5.50 and its two-hundred day moving average is $6.77.
Institutional Trading of Gyrodyne
A hedge fund recently bought a new position in Gyrodyne stock. Advisory Services Network LLC bought a new position in Gyrodyne , LLC (NASDAQ:GYRO – Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 7,720 shares of the real estate investment trust’s stock, valued at approximately $77,000. Advisory Services Network LLC owned approximately 0.35% of Gyrodyne at the end of the most recent quarter. 71.36% of the stock is currently owned by institutional investors and hedge funds.
About Gyrodyne
Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.
The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.
Featured Stories
- Five stocks we like better than Gyrodyne
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.
